Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 23, 2021

SELL
$32.46 - $40.48 $1.64 Million - $2.04 Million
-50,454 Closed
0 $0
Q1 2021

Apr 27, 2021

SELL
$33.61 - $49.95 $923,905 - $1.37 Million
-27,489 Reduced 35.27%
50,454 $1.72 Million
Q4 2020

Feb 03, 2021

BUY
$26.52 - $49.35 $2.07 Million - $3.85 Million
77,943 New
77,943 $3.54 Million
Q3 2020

Oct 27, 2020

SELL
$27.01 - $40.26 $1.35 Million - $2.01 Million
-50,042 Closed
0 $0
Q2 2020

Aug 04, 2020

BUY
$27.75 - $43.44 $1.39 Million - $2.17 Million
50,042 New
50,042 $1.84 Million
Q4 2019

Jan 31, 2020

SELL
$34.54 - $44.87 $1.67 Million - $2.17 Million
-48,400 Closed
0 $0
Q3 2019

Oct 23, 2019

BUY
$31.84 - $50.88 $1.54 Million - $2.46 Million
48,400 New
48,400 $1.72 Million

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $420M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track State Of New Jersey Common Pension Fund D Portfolio

Follow State Of New Jersey Common Pension Fund D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

News

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.